JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, J. V.
Right arrow Articles by Richards, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, J. V.
Right arrow Articles by Richards, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OUABAIN
*RESERPINE
Journal of Pharmacology And Experimental Therapeutics, Vol. 147, Issue 2, 205-211, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


THE INFLUENCE OF RESERPINE PRETREATMENT ON THE CONTRACTILE AND METABOLIC EFFECTS PRODUCED BY OUABAIN ON ISOLATED RABBIT LEFT ATRIA

Joseph V. Levy 1 and V. Richards 1

1 Research Laboratories, Presbyterian Medical Center, San Francisco, California

Pretreatment of rabbits with reserpine (1.0 mg/kg i.v.) significantly attenuated the positive inotropic response of electrically driven isolated left atria to a nontoxic concentration of ouabain (8.3 x 10-7 M) as measured by both per cent and absolute change in force. However, the absolute maximum contraction force (in grams) developed by the reserpinized atria was not significantly different from that seen in the normal atria. Reserpine pretreatment (5.0 mg/kg i.v.) did not prevent the toxic effects of ouabain (3.35 x l0-6 M).

Chronic (3.0 mg/kg i.p. for 3 days) or acute reserpinization did not affect oxygen consumption of isolated left atria. In vitro reserpinization (1.0 and 10.0 ggrg/ml) also failed to affect atrial O2 consumption compared to controls.

Reserpine pretreatment, either in vivo or in vitro did not modify the normal stimulatory effect of ouabain (2.8 x 10-6 M) on atrial O2 consumption. In addition, dichloroisoproterenol (DCI) in a concentration reported to block the positive inotropic effects of ouabain on the cat papillary muscle failed to modify the usual ouabain-induced augmentation of atrial O2 consumption.

The data presented here and elsewhere are generally compatible with the view that the modification of the contractile responses to nontoxic concentrations of ouabain in appropriately reserpinized muscle is due in part to the absence or unavailability of endogenous catecholamines required for the production of ouabain-induced augmentation of contraction. However, other changes caused by reserpinization cannot be excluded as factors possibly contributing to the altered ouabain effects. Our data are not consonant with time hypothesis timat an altered oxidative metabolism resulting from reserpinization is involved in the attenuation of the contraction responses to nontoxic concentrations of ouabain in rabbit atrial tissue.

Accepted on October 12, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.